Skip to main content
Sam S. Chang, MD, Urology, Nashville, TN

Sam S. Chang MD MBA

Surgical Oncology


Patricia and Rodes Hart Endowed Professor, Professor of Urology and Oncology, Chief Surgical Officer, Vanderbilt Ingram Cancer Center

Join to View Full Profile
  • 3601 21st Ave SNashville, TN 37232

  • Phone+1 615-322-3000

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 1998 - 2000
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Urology, 1994 - 1998
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Surgery, 1992 - 1994
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1992
  • Princeton University
    Princeton UniversityA.B., Politics, 1984 - 1988

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2000 - 2028
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • FL State Medical License
    FL State Medical License 2015 - 2020
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification StarPanel, Vanderbilt University, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification BI-Clinical, CitiusTech, Inc., 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target  
    Melody Xu, Felix Y Feng, Corey Speers, Shuang G Zhao, S Laura Chang, Journal of the National Cancer Institute

Lectures

  • SESAUA 77th Annual Meeting 
    Southeastern Section of the AUA, Williamsburg, Virginia - 3/14/2013

Press Mentions

  • SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant
    SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research GrantDecember 2nd, 2025
  • Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
    Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder CancerJune 13th, 2025
  • Advanced Cases of Prostate Cancer Are Increasing After Years of Decline
    Advanced Cases of Prostate Cancer Are Increasing After Years of DeclineSeptember 21st, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: